Skip to main content
Top
Published in: Substance Abuse Treatment, Prevention, and Policy 1/2008

Open Access 01-12-2008 | Research

Comparison of CO breath testing and women's self-reporting of smoking behaviour for identifying smoking during pregnancy

Authors: Zara C Usmani, Pauline Craig, Deborah Shipton, David Tappin

Published in: Substance Abuse Treatment, Prevention, and Policy | Issue 1/2008

Login to get access

Abstract

Background

Healthcare services often use a carbon monoxide (CO) breath test to validate self-reported smoking and to assess reductions in smoking habit. A cut-off level of ≥ 8 parts per million (p.p.m.) is used to identify smoking. This cut-off requires further validation in pregnant women.

Methods

Data on self-reported smoking were assessed in conjunction with breath CO levels. Subjects in the study were 2548 women attending antenatal booking during 12 months.

Results

546/2584 (21.4%) women self-reported as current smokers. A cut-off of 8 ppm identified only 325/546 self-reported smokers (sensitivity 59.4%). 27/2002 self-reported non-smokers had levels greater than 8 ppm (specificity 98.7%). Sensitivity and specificity analysis revealed that CO cut-off levels of 2 or 3 p.p.m. resulted in the best sensitivity and specificity for discriminating apparent smokers and non-smokers. A cut-off of 2 p.p.m. would have identified 468/546 of self-reported smokers (sensitivity 86%). 206/2002 self-reported non-smokers had levels > 2 ppm (specificity 90 %). If all these women were 'true' smokers, the real prevalence of smoking in pregnancy was 26.5% (752/2548) and 27% of true smokers provided false answers to the self-reported question at maternity booking.

Conclusion

At 8 ppm, many smokers are missed and there may be gross underestimating of levels of smoking in a pregnant population. Results emphasise the need to support a lower cut-off level for the breath CO test closer to 2 or 3 p.p.m. These cut-offs may be more appropriate in the antenatal clinic setting, and are in line with recent recommendations in the non-pregnant population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Sattar N: Do pregnancy complications and CVD share common antecedents?. Atheroscler Suppl. 2004, 5: 3-7. 10.1016/j.atherosclerosissup.2004.03.002.CrossRefPubMed Sattar N: Do pregnancy complications and CVD share common antecedents?. Atheroscler Suppl. 2004, 5: 3-7. 10.1016/j.atherosclerosissup.2004.03.002.CrossRefPubMed
2.
go back to reference Olds D: Tobacco exposure and impaired development: A review of the evidence. Mental Retardation and Developmental Disabilities Research Reviews. 1997, 3: 257-269. 10.1002/(SICI)1098-2779(1997)3:3<257::AID-MRDD6>3.0.CO;2-M.CrossRef Olds D: Tobacco exposure and impaired development: A review of the evidence. Mental Retardation and Developmental Disabilities Research Reviews. 1997, 3: 257-269. 10.1002/(SICI)1098-2779(1997)3:3<257::AID-MRDD6>3.0.CO;2-M.CrossRef
3.
go back to reference Dempsey D, Jacob P, Benowitz NL: Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002, 301: 594-8. 10.1124/jpet.301.2.594.CrossRefPubMed Dempsey D, Jacob P, Benowitz NL: Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002, 301: 594-8. 10.1124/jpet.301.2.594.CrossRefPubMed
4.
go back to reference Dolan-Mullen P, Ramirez G, Groff JY: A meta-analysis of randomized trials of prenatal smoking cessation interventions. Am J Obstet Gynecol. 1994, 171: 1328-34.CrossRefPubMed Dolan-Mullen P, Ramirez G, Groff JY: A meta-analysis of randomized trials of prenatal smoking cessation interventions. Am J Obstet Gynecol. 1994, 171: 1328-34.CrossRefPubMed
5.
go back to reference Lumley J, Oliver SS, Chamberlain C, Oakley L: Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2004, CD001055-DOI: 10.1002/14651858.CD001055.pub2, 4 Lumley J, Oliver SS, Chamberlain C, Oakley L: Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev. 2004, CD001055-DOI: 10.1002/14651858.CD001055.pub2, 4
6.
go back to reference McClure JB: Motivating prepartum smoking cessation: A consideration of biomarker feedback. Nicotine Tob Res. 2004, 6: S153-61. 10.1080/14622200410001669222.CrossRefPubMed McClure JB: Motivating prepartum smoking cessation: A consideration of biomarker feedback. Nicotine Tob Res. 2004, 6: S153-61. 10.1080/14622200410001669222.CrossRefPubMed
7.
go back to reference Bize R, Burnand B, Mueller Y, Cornuz J: Effectiveness of biomedical risk assessment as an aid for smoking cessation: a systematic review. Tob Control. 2007, 16: 151-156. 10.1136/tc.2006.017731.PubMedCentralCrossRefPubMed Bize R, Burnand B, Mueller Y, Cornuz J: Effectiveness of biomedical risk assessment as an aid for smoking cessation: a systematic review. Tob Control. 2007, 16: 151-156. 10.1136/tc.2006.017731.PubMedCentralCrossRefPubMed
8.
go back to reference Patrick DL, Cheadle A, Thompson MS, Diehr P, Koepsell T, Kinne S: The validity of self-reported smoking: a review and meta-analysis. American Journal of Public Health. 1994, 84: 1086-1093.PubMedCentralCrossRefPubMed Patrick DL, Cheadle A, Thompson MS, Diehr P, Koepsell T, Kinne S: The validity of self-reported smoking: a review and meta-analysis. American Journal of Public Health. 1994, 84: 1086-1093.PubMedCentralCrossRefPubMed
9.
go back to reference Ford RPK, Tappin DM, Schluter PJ, Wild CJ: Smoking during pregnancy: how reliable are maternal self reports in New Zealand?. Journal of Epidemiology and Community Health. 1997, 51 (3): 246-51.PubMedCentralCrossRefPubMed Ford RPK, Tappin DM, Schluter PJ, Wild CJ: Smoking during pregnancy: how reliable are maternal self reports in New Zealand?. Journal of Epidemiology and Community Health. 1997, 51 (3): 246-51.PubMedCentralCrossRefPubMed
10.
go back to reference Benowitz NL, Jacob P: Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 1994, 56: 483-93.CrossRefPubMed Benowitz NL, Jacob P: Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 1994, 56: 483-93.CrossRefPubMed
11.
go back to reference Dempsey D, Jacob P, Benowitz NL: Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002, 301: 594-8. 10.1124/jpet.301.2.594.CrossRefPubMed Dempsey D, Jacob P, Benowitz NL: Accelerated metabolism of nicotine and cotinine in pregnant smokers. J Pharmacol Exp Ther. 2002, 301: 594-8. 10.1124/jpet.301.2.594.CrossRefPubMed
13.
go back to reference Frederiksen LW, Martin JE: Carbon monoxide and smoking behavior. Addictive Behaviors. 1979, 4: 21-30. 10.1016/0306-4603(79)90017-0.CrossRefPubMed Frederiksen LW, Martin JE: Carbon monoxide and smoking behavior. Addictive Behaviors. 1979, 4: 21-30. 10.1016/0306-4603(79)90017-0.CrossRefPubMed
14.
go back to reference Secker-Walker RH, Vacek PM, Flynn BS, Meads PB: Exhaled carbon monoxide and urinary cotinine as measures of smoking in pregnancy. Addictive Behaiviors. 1997, 22 (5): 671-684. 10.1016/S0306-4603(97)00013-0.CrossRef Secker-Walker RH, Vacek PM, Flynn BS, Meads PB: Exhaled carbon monoxide and urinary cotinine as measures of smoking in pregnancy. Addictive Behaiviors. 1997, 22 (5): 671-684. 10.1016/S0306-4603(97)00013-0.CrossRef
16.
go back to reference Benowitz NL, Jacob P, Ahijevych K, Jarvis MF, Hall S, LeHouezec J, Hansson A, Lichtenstein E, Henningfield J, Tsoh J, Hurt RD, Velicer W: Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research. 2002, 4: 149-159. 10.1080/14622200210123581.CrossRef Benowitz NL, Jacob P, Ahijevych K, Jarvis MF, Hall S, LeHouezec J, Hansson A, Lichtenstein E, Henningfield J, Tsoh J, Hurt RD, Velicer W: Biochemical verification of tobacco use and cessation. Nicotine and Tobacco Research. 2002, 4: 149-159. 10.1080/14622200210123581.CrossRef
17.
go back to reference Javors MA, Hatch JP, Lamb RJ: Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction. 2005, 100: 159-67. 10.1111/j.1360-0443.2004.00957.x.CrossRefPubMed Javors MA, Hatch JP, Lamb RJ: Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction. 2005, 100: 159-67. 10.1111/j.1360-0443.2004.00957.x.CrossRefPubMed
18.
go back to reference Higgins ST, Heil SH, Badger GJ, Mongeon JA, Solomon LJ, McHale L, Bernstein IM: Biochemical verification of smoking status in pregnant and recently postpartum women. Exp Clin Psychopharmacol. 2007, 15: 58-66. 10.1037/1064-1297.15.1.58.CrossRefPubMed Higgins ST, Heil SH, Badger GJ, Mongeon JA, Solomon LJ, McHale L, Bernstein IM: Biochemical verification of smoking status in pregnant and recently postpartum women. Exp Clin Psychopharmacol. 2007, 15: 58-66. 10.1037/1064-1297.15.1.58.CrossRefPubMed
20.
go back to reference Windsor RA, Orleans CT: Guidelines and methodological standards for smoking cessation intervention research among pregnant women: improving the science and art. Health Educ Q. 1986, 13: 131-61.CrossRefPubMed Windsor RA, Orleans CT: Guidelines and methodological standards for smoking cessation intervention research among pregnant women: improving the science and art. Health Educ Q. 1986, 13: 131-61.CrossRefPubMed
21.
go back to reference Mas R, Escriba V, Colomer C: Who quits smoking during pregnancy?. Scand J Soc Med. 1996, 24: 102-6.PubMed Mas R, Escriba V, Colomer C: Who quits smoking during pregnancy?. Scand J Soc Med. 1996, 24: 102-6.PubMed
22.
go back to reference Ford RPK, Tappin DM, Schluter PJ, Wild CJ: Smoking during pregnancy: how reliable are maternal self-reports in New Zealand?. Epidemiology and Community Health. 1997, 51 (3): 246-51.CrossRef Ford RPK, Tappin DM, Schluter PJ, Wild CJ: Smoking during pregnancy: how reliable are maternal self-reports in New Zealand?. Epidemiology and Community Health. 1997, 51 (3): 246-51.CrossRef
Metadata
Title
Comparison of CO breath testing and women's self-reporting of smoking behaviour for identifying smoking during pregnancy
Authors
Zara C Usmani
Pauline Craig
Deborah Shipton
David Tappin
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Substance Abuse Treatment, Prevention, and Policy / Issue 1/2008
Electronic ISSN: 1747-597X
DOI
https://doi.org/10.1186/1747-597X-3-4

Other articles of this Issue 1/2008

Substance Abuse Treatment, Prevention, and Policy 1/2008 Go to the issue